Our leadership team

Joined in 2023.

Michael took the helm of the business in April 2024, having previously been Chief Strategy Officer.

He joined from Philip Morris International, where he held several positions of increasing responsibility, including Senior Vice President, Commercialization. He was previously a Senior Partner at management consulting firm, Bain & Company.

He has decades of experience within the pharmaceutical and consumer health industries in commercial strategy, and has a deep understanding of consumer, physician, payor, and patient perspectives.

Michael has a Bachelor’s and Master’s degree in Business Administration from European Business School in Germany.

Joined in 2022.

Prior to his appointment as Chief Financial Officer, Sylvain was Chief Financial Officer Europe for Novartis Institutes for BioMedical Research. He has more than 20 years’ experience in finance and business.

Previously, he was country Chief Financial Officer for Novartis Pharmaceuticals in Asia. Sylvain started his career as an Audit Manager at Arthur Andersen, Ernst & Young, and KPMG.

Sylvain has an MBA from INSEAD Business School, a Master’s degree in Finance from Grenoble Business School, a Bachelor’s degree in Economics from Université Louis Pasteur, France, and is a certified public accountant.

Joined in 2025.

Prior to his appointment as Chief People & Culture Officer, Laurent was Vice President People & Culture Transformation at Philip Morris International.

He has more than 20 years’ experience in People & Culture roles with Philip Morris International, covering operating models, compensation and benefits, as well as leadership and development, and leading People & Culture functions in Germany and Sweden.

Laurent has an MBA from University of St.Gallen, Switzerland, and a Master’s degree in Economics from HEC Lausanne, Switzerland.

Joined in 2022.

Prior to his appointment as Vice President IT, Tomek was the Chief Digital Officer at Polpharma.

He has more than 30 years’ experience developing the strategic digital and IT capabilities required to support the delivery of a company’s strategy, and a wealth of technology experience within blue-chip companies across multiple markets and industry sectors. Tomek also has broad experience in digital health and digital healthcare consumer solutions.

Previously, Tomek held senior technology and information systems roles at Walgreens Boots Alliance and Heineken.

Tomek has an MBA from the joint program of Strathclyde University, UK and the University of Gdańsk, Poland, and a Master’s degree in Telecommunications from the Technical University of Gdańsk, Poland.

Joined in 2024.

Prior to her appointment as Assistant General Counsel Life Sciences, Rosana was Senior Director and Head of Legal for the global commercial and global scientific affairs departments at Mundipharma.

She has more than a decade of experience holding counsel roles for large corporations across different industries with a focus on commercial, corporate, and pharmaceutical law.

Previously, Rosana held legal and compliance roles at Hasbro and DSM Nutritional Products Ltd.

Rosana is admitted to the Swiss Bar (and license to register as civil law notary) and has a Master of Laws degree (LLM) from the William S. Richardson School of Law, University of Hawaii, US.

Joined in 2023.

Prior to her appointment as Chief Business Development & Licensing Officer, Begoña was Worldwide Head BD&L of the Opthalmology Franchise at Novartis.

She has more than 20 years’ experience in licensing deals, business development, and M&A.

Previously she held senior roles within Novartis and at Almirall.

Begoña has a PhD in Drug Delivery and completed a three-year Postdoctoral Research fellowship, both at the London School of Pharmacy (now UCL School of Pharmacy), and has a Bachelor’s degree in Biochemistry from Keele University, UK.

Joined in 2022.

Prior to her appointment as Chief Quality Officer, Annika was Global Vice President of Quality Assurance & Regulatory Affairs at the Division of Immunodiagnostics at Thermo Fisher Scientific.

She has more than 35 years’ experience in the pharma, biotech, life sciences, and diagnostics industries.

Previously, Annika held senior roles at Agilent Technologies, GE Healthcare, and Pfizer.

Annika has a Licentiate of Philosophy in Analytical Chemistry and Chemometrics, and a Bachelor’s degree in Analytical Chemistry from Uppsala University, Sweden.

Joined in 2024.

Prior to his appointment as Chief Medical Officer, Thomas was Head Global Clinical Development. He has more than 20 years of experience and leadership in pharmaceutical development.

Previously, Thomas held senior roles at Coave Therapeutics, Orphazyme, Roche, Bristol-Myers Squibb, and Novartis.

Thomas has an MD from the University of Zurich and board certification from the Swiss Society of Neurology.

Joined in 2022.

Prior to his appointment as Chief Consumer Health Officer, Kim was Vice President Consumer & Digital Health at Phillip Morris International.

He has more than 20 years’ experience of creating value within dietary supplements, early life nutrition, medical nutrition, food and beverage, and pharma industries.

Previously, Kim held various roles at DSM, Chr.Hansen (now Novonesis), and Boston Consulting Group.

Kim has a PhD in Biochemistry from Michigan State University, US, and an Executive MBA from London Business School, UK. He has a Master’s and Bachelor’s degree in Chemistry from Aarhus University, Denmark.

Joined in 2022.

Prior to her appointment as Vice President Innovation & Product Development (Cannabinoids), Julia was Global Head Discovery Life Sciences at Philip Morris International.

She has more than 20 years’ experience working within industry across multiple areas of science and product development, ranging from inhalation toxicology to drug discovery and tobacco harm reduction.

Julia has a PhD in Molecular Biology from the University of Cambridge, UK, an Executive MBA from the Business School Lausanne, Switzerland, a Master’s degree in Bioinformatics from Georgia Institute of Technology, US, and a Bachelor’s degree in Biology from Guilford College, US.

Joined in 2023.

Prior to his appointment as Category Head, Nicotine Replacement Therapy (NRT), Joel was President at Niconovum AB.

He has more than 20 years’ experience in business development and commercial roles, predominately in consumer healthcare, with extensive expertise in global NRT brand strategy.

Previously, Joel was Global Marketing Director at GlaxoSmithKline, and Vice President of Brand Strategy Consulting at Nielsen.

Joel has an MBA from The London Business School, UK, a Master’s degree in Public Administration from New York University, US, and a Bachelor’s degree in Economics from Columbia University, US.

Joined in 2023.

Prior to his appointment as Managing Director, Oral CDMO, Michael was Chief Financial Officer at Fertin Pharma.

He has a wealth of experience from his previous Chief Financial Officer roles across a number of industries. Previously, Michael held financial auditor roles with Arthur Andersen and Deloitte.

Michael has a Master’s degree in Business Economics and Auditing, and a Bachelor’s degree in Economics and Business Administration from Aarhus University, Denmark.

Joined in 2024.

Malene is Vice President, Innovation & New Product Development.

Malene was previously Vice President, R&D Portfolio & Program Leadership at LEO Pharma, and has more than 20 years’ R&D experience in drug development, project and portfolio management, and regulatory affairs, across the pharmaceutical and biotech industry.

Malene has a Master’s degree in Pharmacy from the Royal Danish School of Pharmacy, a Bachelor’s degree in leadership from the Danish School of Engineering, and a Global Management Certification from INSEAD.

Joined in 2024.

Henri is Vice President, Global Operations & Supply Chain Management.

Henri has 25 years’ experience in global manufacturing, production, outsourcing, distribution, and supply chains, having managed factory sites for Hamlet Protein, GumLink A/S, and Rynkeby Foods in previous roles. He is also a board member at Motus Nordic Group.

Henri has a Diploma in Production Engineering from the University of Southern Denmark, and a Business Insight Certification from INSEAD.

Joined in 2025.

Prior to her appointment as Director Strategic Initiatives, Karine held various roles in driving organizational change and business transformation at Philip Morris International and Kearney.

She brings more than 15 years’ experience in corporate strategy, transformation, mergers and acquisition, and business development.

Karine holds an MBA from ESCP Business School, France, and a Master’s degree in Life Sciences Engineering from AgroParisTech, France.

Joined in 2024.

Prior to his appointment, Richard was Director Communications at Vectura Group.

Richard has more than 20 years’ experience of broad corporate communications roles, having previously worked for G4S, Inmarsat, and BAE Systems.

Richard has a Master’s degree in Applied Environmental Geology from Cardiff University, and a Bachelor’s degree in Geology from the University of Southampton.